display

Like the European Medicines Agency (EMA), the Standing Vaccination Commission (Stiko) in Germany has come to the conclusion that Astrazeneca's corona vaccine can continue to be used.

"The benefit of the vaccination outweighs the currently known risks," announced the Stiko on Friday.

The approval authorities in France and Denmark were more cautious.

The data available to Stiko on the rare cases of a form of thrombosis that have become known showed a so-called safety signal, the commission said.

But there is still no certainty.

"Stiko will closely follow, continuously check and evaluate all expected data." Should the need arise to restrict the groups for which the vaccine is considered suitable, Stiko will take this into account "immediately" in its vaccination recommendation.

The corona vaccinations with the preparation from Astrazeneca, which had been stopped as a precaution, should start again on Friday in Germany after they had been suspended since Monday due to several cases of rare thrombosis in the cerebral veins.

The EMA reaffirmed the safety of the vaccine on Thursday.

But an extra warning about the possible rare blood clots will be added.

display

Denmark,

on the other hand, does not want to use AstraZeneca's corona vaccine again for the time being.

First, the decision of the EMA "and its impact on the Danish vaccination program" should be examined, said the head of the health authority, Soren Brostrom.

The EMA had assessed the vaccine as “safe and effective”, but at the same time it had not ruled out a connection with dangerous blood clots.

In Denmark, ten cases of severe blood clots are currently being investigated after AstraZeneca vaccinations, including one death.

In total, more than 140,000 Danes received the vaccine.

The country became the first country in Europe to suspend vaccinations after reports of the blood clots last week.

Several other countries, including Germany, subsequently issued a vaccination ban.

France expresses a restriction

In France, only people over the age of 55 should now receive the AstraZeneca vaccine.

This was recommended by the country's health authority (HAS) in Paris on Friday.

The reason for the recommendation is that the life-threatening blood clots mainly occurred in younger people.

In order to strengthen the confidence of the population after the temporary suspension of the AstraZeneca vaccine, the French Prime Minister Jean Castex wants to have the vaccine administered on Friday.

Castex will be vaccinated in the Begin military hospital near Paris, reports the broadcaster BFM TV.

The Prime Minister announced the move on Thursday when the EMA recommended the resumption of vaccinations with the AstraZeneca active ingredient.